Applications
LC/MS/MS Analysis of Digoxin and Digitoxin in plasma (0.5 ng/mL) using Strata-X and Kinetex C8
19692
Separation Mode: Reversed Phase
Reversed Phase
C8
HPLC
Anti-Arrhythmia Agents
Clinical

Applications

LC/MS/MS Analysis of Digoxin and Digitoxin in plasma (0.5 ng/mL) using Strata-X and Kinetex C8
Analytes
1
2
3
Compound Name
Digoxin
CID
30322
Molecular Formula
C41H64O14
Molecular Weight
780
No. Chiral Centers:
1
No. Hydrogen Bond Acceptors
14
No. Hydrogen Bond Donors
6
Details
LC Conditions (App ID: 19692)
Column:
Brand Name:
Part No:
Elution Type:
Gradient
Mobile Phase:
A: 10mM Ammonium acetate
B: 10mM Ammonium acetate in methanol
Gradient Profile:
Step No.Time(min)%A%B
105050
22.50100
32.515050
455050
Flow Rate:
400 µL/min
Temperature:
30°C
Detection:
Mass Spectrometer (MS) amu @ 350°C
Sample Preparation Details
Description:
Strata-X 33 µm Polymeric Reversed Phase, 30 mg / 3 mL, Tubes, 50/Pk
Part Number:
SPE Condition 1:
2 mL Methanol at 2 mL/min
SPE Condition 2:
2 mL 10mM Ammonium acetate at 2 mL/min
SPE Load:
Load 3.00 mL Sample diluted in Water
SPE Wash 1:
1 mL 50:50 10mM ammonium acetate/10mM ammonium acetate in methanol at 2 mL/min
SPE Dry:
10min at full vacuum
SPE Elution 1:
2 mL Methanol at 1 mL/min
SPE Evaporation:
Evaporate to dryness
SPE Reconstitute:
100 µL 50:50 Methanol/water

Order Items Used in This Application

Similar Applications
search
Kinetex 2.6 µm C8 100 Å, LC Column 50 x 2.1 mm, Ea
Reversed Phase
Kinetex 2.6 µm C8 100 Å, LC Column 50 x 2.1 mm, Ea
Reversed Phase
Kinetex 2.6 µm C8 100 Å, LC Column 50 x 2.1 mm, Ea
Reversed Phase